The scientist who discovered the gene responsible for causing Huntington’s disease continues his pursuit for other gene targets.
The Price of Personalization
Tailoring treatments, patient by patient, can achieve remarkable results. But can we afford to make every disease rare?
Our Dark Matter
Genes account for less than 2% of the human genome—and much of what determines health and disease may lie elsewhere.
The Trouble with Targeting Treatments
Researchers are working to develop diagnostic tests to determine who is eligible for targeted therapies, but red tape and limited expertise stand in the way.